腹主动脉瘤开放与腔内治疗的长期结局:基于重建时间-事件数据的系统评价与Meta分析
该系统评价与Meta分析纳入13项随机对照试验和倾向评分匹配队列研究,比较择期腹主动脉瘤开放手术修复(OSR)与腔内修复(EVAR)的总体生存率和免于再干预率。共纳入OSR组13409例和EVAR组13450例。结果显示EVAR在术后第一年(尤其前11个月)有生存优势,但OSR在11个月后至180个月有晚期生存获益,且再干预风险更低。
要点
- EVAR在术后前11个月生存优于OSR(HR=1.37,95%CI 1.22-1.54,p<0.0001)。
- OSR在11个月后至180个月生存优于EVAR(HR=0.84,95%CI 0.8-0.89,p<0.0001)。
- EVAR在术后30天内免于再干预更优(HR=1.28,95%CI 1.14-1.44,p<0.0001),但1个月后至168个月OSR更优(HR=0.73,95%CI 0.66-0.79,p<0.0001)。
核心结论
- 尽管EVAR在择期腹主动脉瘤修复患者中具有第一年生存优势,但OSR在长期随访中与晚期生存获益和再干预风险降低相关。
研究设计与样本
- 系统评价与Meta分析,检索PubMed、Scopus和Cochrane数据库,纳入报告相关结局的随机对照试验和倾向评分匹配队列研究,由2名独立研究者按PRISMA声明进行文献筛选。
- 共纳入13项研究,OSR组13409例,EVAR组13450例。
- 采用Kaplan-Meier衍生时间-事件数据进行一阶段和二阶段Meta分析,并使用随机效应模型。
主要发现
- OSR组总体生存率优于EVAR组(HR=0.93,95%CI 0.88-0.98,p=0.004),平均随访53.8个月(SD=29.8)。
- 二阶段Meta分析验证OSR组生存获益(HR=0.89,95%CI 0.8-0.99,p=0.03,I²=62.25%)。
- 时间分割分析显示,择期干预后前11个月内EVAR生存结局优于OSR(HR=1.37,95%CI 1.22-1.54,p<0.0001)。
- 11个月后至180个月,OSR显示显著生存优势(HR=0.84,95%CI 0.8-0.89,p<0.0001)。
- 术后前30天内EVAR组免于再干预显著更优(HR=1.28,95%CI 1.14-1.44,p<0.0001);术后1个月后至168个月,OSR组免于再干预率更高(HR=0.73,95%CI 0.66-0.79,p<0.0001)。
局限性
- 二阶段Meta分析存在异质性(I²=62.25%)。
- 作者指出需要额外研究来阐明在微创技术不断发展的时代,开放手术修复与最新腔内器械和技术相比的意义。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The advent of endovascular techniques has revolutionized the care of patients with uncomplicated abdominal aortic aneurysms. This analysis compares the overall survival and the freedom from reintervention rate between open surgical repair (OSR) and endovascular repair (EVAR) in patients undergoing elective abdominal aortic aneurysm (AAA) repair. METHODS: PubMed, Scopus, and Cochrane databases were searched for studies including patients who underwent either OSR or EVAR for uncomplicated AAA. All randomized controlled trials and propensity-score-matched cohort studies reporting on the outcomes of interest were considered eligible for inclusion. The systematic search of the literature was performed by 2 independent investigators in accordance with the recommendations of the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) statement. We conducted 1-stage and 2-stage meta-analyses with Kaplan-Meier-derived time-to-event data and meta-analysis with a random-effects model. RESULTS: Thirteen studies met our eligibility criteria, incorporating 13 409 and 13 450 patients in the OSR and EVAR arms, respectively. Patients who underwent open repair had improved overall survival rates compared with those who underwent EVAR (hazard ratio [HR]=0.93, 95% confidence interval [CI]=0.88-0.98, p=0.004) during a mean follow-up of 53.8 (SD=29.8) months and this was validated by the 2-stage meta-analysis (HR=0.89, 95% CI=0.8-0.99, p=0.03, I2=62.25%). Splitting timepoint analysis suggested that EVAR offers better survival outcome compared with OSR in the first 11 months following elective intervention (HR=1.37, 95% CI=1.22-1.54, p<0.0001), while OSR offers a significant survival advantage after the 11-month timepoint and up to 180 months (HR=0.84, 95% CI=0.8-0.89, p<0.0001). Similarly, freedom from reintervention was found to be significantly better in EVAR patients (HR=1.28, 95% CI=1.14-1.44, p<0.0001) within the first 30 days. After the first month postrepair, however, OSR demonstrated higher freedom-from-reintervention rates compared with EVAR that remained significant for up to 168 months during follow-up (HR=0.73, 95% CI=0.66-0.79, p<0.0001). CONCLUSIONS: Despite the first-year survival advantage of EVAR in patients undergoing elective AAA repair, OSR was associated with a late survival benefit and decreased risk for reintervention in long-term follow-up.Clinical ImpactOpen surgical repair for uncomplicated abdominal aortic aneurysm offers better long-term outcomes in terms of survival and freedom from reintervention rate compared to the endovascular approach but in the first year it carries a higher risk of mortality. The novelty of our study lies that instead of comparing study-level effect estimates, we analyzed reconstructed individual patient-level data. This offered us the opportunity to perform our analyses with mathematically robust and flexible survival models, which was proved to be crucial since there was evidence of different hazard over time. Our findings underline the need for additional investigation to clarify the significance of open surgical repair when compared to the latest endovascular devices and techniques within the evolving era of minimally invasive procedures.
引用
- Loufopoulos G, Tasoudis P, Koudounas G, et al. Long-Term Outcomes of Open Versus Endovascular Treatment for Abdominal Aortic Aneurysm: Systematic Review and Meta-Analysis With Reconstructed Time-to-Event Data. J Endovasc Ther. 2023. PMID: 37855415. doi:10.1177/15266028231204805
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。